David S. Tierney, President and CEO of Valera Pharmaceuticals, Inc.,
Rings The NASDAQ Stock Market Opening Bell

Tuesday, June 6, 2006
at NASDAQ's MarketSite
in New York City.

Valera Pharmaceuticals, Inc [VLRX]

David S. Tierney, President and CEO of Valera Pharmaceuticals, Inc (Nasdaq: VLRX) presides over the opening bell to celebrate its initial public offering on the NASDAQ.

Valera Pharmaceuticals is a specialty pharmaceutical company engaged in the development, acquisition, and commercialization of products to treat urology and endocrinology diseases and disorders. Valera applies its Hydron technology to develop compact, flexible implants that can release therapeutics at a controlled rate for up to twelve months. VANTAS(R), a once-per-year implant currently marketed by Valera for the palliative treatment of advanced prostate cancer, employs this drug delivery technology.

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 6/6/2006 Download Hi-Res Quality Photo of this NASDAQ Market Open - Pictured: David S. Tierney, President and CEO of Valera Pharmaceuticals, Inc, rings the Opening Bell These photos are Copyright 2006, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2006, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.